1
|
Licón-Muñoz Y, Avalos V, Subramanian S, Granger B, Martinez F, Varela S, Moore D, Perkins E, Kogan M, Berto S, Chohan M, Bowers C, Piccirillo S. Single-nucleus and spatial landscape of the sub-ventricular zone in human glioblastoma. bioRxiv 2024:2024.04.24.590852. [PMID: 38712234 PMCID: PMC11071523 DOI: 10.1101/2024.04.24.590852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2024]
Abstract
The sub-ventricular zone (SVZ) is the most well-characterized neurogenic area in the mammalian brain. We previously showed that in 65% of patients with glioblastoma (GBM), the SVZ is a reservoir of cancer stem-like cells that contribute to treatment resistance and emergence of recurrence. Here, we built a single-nucleus RNA-sequencing-based microenvironment landscape of the tumor mass (T_Mass) and the SVZ (T_SVZ) of 15 GBM patients and 2 histologically normal SVZ (N_SVZ) samples as controls. We identified a mesenchymal signature in the T_SVZ of GBM patients: tumor cells from the T_SVZ relied on the ZEB1 regulatory network, whereas tumor cells in the T_Mass relied on the TEAD1 regulatory network. Moreover, the T_SVZ microenvironment was predominantly characterized by tumor-supportive microglia, which spatially co-exist and establish heterotypic interactions with tumor cells. Lastly, differential gene expression analyses, predictions of ligand-receptor and incoming/outgoing interactions, and functional assays revealed that the IL-1β/IL-1RAcP and Wnt-5a/Frizzled-3 pathways are therapeutic targets in the T_SVZ microenvironment. Our data provide insights into the biology of the SVZ in GBM patients and identify specific targets of this microenvironment.
Collapse
Affiliation(s)
- Y. Licón-Muñoz
- The Brain Tumor Translational Laboratory, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
| | - V. Avalos
- The Brain Tumor Translational Laboratory, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
| | - S. Subramanian
- Bioinformatics Core, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
- Neurogenomics Laboratory, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
| | - B. Granger
- Bioinformatics Core, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
- Neurogenomics Laboratory, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
| | - F. Martinez
- The Brain Tumor Translational Laboratory, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
| | - S. Varela
- University of New Mexico School of Medicine, Albuquerque, NM
| | - D. Moore
- Bioinformatics Core, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
- Neurogenomics Laboratory, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
| | - E. Perkins
- Department of Neurosurgery, University of Mississippi Medical Center, Jackson, MS
| | - M. Kogan
- Department of Neurosurgery, University of New Mexico Hospital, Albuquerque, NM
| | - S. Berto
- Bioinformatics Core, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
- Neurogenomics Laboratory, Department of Neuroscience, Medical University of South Carolina, Charleston, SC
| | - M.O. Chohan
- Department of Neurosurgery, University of Mississippi Medical Center, Jackson, MS
| | - C.A. Bowers
- Department of Neurosurgery, University of New Mexico Hospital, Albuquerque, NM
| | - S.G.M. Piccirillo
- The Brain Tumor Translational Laboratory, Department of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM
- University of New Mexico Comprehensive Cancer Center, Albuquerque, NM
| |
Collapse
|
2
|
Zhou Y, Moon C, Szatkowski J, Moore D, Stevens J. Evaluating ChatGPT responses in the context of a 53-year-old male with a femoral neck fracture: a qualitative analysis. Eur J Orthop Surg Traumatol 2024; 34:927-955. [PMID: 37776392 PMCID: PMC10858115 DOI: 10.1007/s00590-023-03742-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2023] [Accepted: 09/18/2023] [Indexed: 10/02/2023]
Abstract
PURPOSE The integration of artificial intelligence (AI) tools, such as ChatGPT, in clinical medicine and medical education has gained significant attention due to their potential to support decision-making and improve patient care. However, there is a need to evaluate the benefits and limitations of these tools in specific clinical scenarios. METHODS This study used a case study approach within the field of orthopaedic surgery. A clinical case report featuring a 53-year-old male with a femoral neck fracture was used as the basis for evaluation. ChatGPT, a large language model, was asked to respond to clinical questions related to the case. The responses generated by ChatGPT were evaluated qualitatively, considering their relevance, justification, and alignment with the responses of real clinicians. Alternative dialogue protocols were also employed to assess the impact of additional prompts and contextual information on ChatGPT responses. RESULTS ChatGPT generally provided clinically appropriate responses to the questions posed in the clinical case report. However, the level of justification and explanation varied across the generated responses. Occasionally, clinically inappropriate responses and inconsistencies were observed in the generated responses across different dialogue protocols and on separate days. CONCLUSIONS The findings of this study highlight both the potential and limitations of using ChatGPT in clinical practice. While ChatGPT demonstrated the ability to provide relevant clinical information, the lack of consistent justification and occasional clinically inappropriate responses raise concerns about its reliability. These results underscore the importance of careful consideration and validation when using AI tools in healthcare. Further research and clinician training are necessary to effectively integrate AI tools like ChatGPT, ensuring their safe and reliable use in clinical decision-making.
Collapse
Affiliation(s)
- Yushy Zhou
- Department of Surgery, The University of Melbourne, St. Vincent's Hospital Melbourne, 29 Regent Street, Clinical Sciences Block Level 2, Melbourne, VIC, 3010, Australia.
- Department of Orthopaedic Surgery, St. Vincent's Hospital, Melbourne, Australia.
| | - Charles Moon
- Department of Orthopaedic Surgery, Cedars-Sinai Medical Centre, Los Angeles, CA, USA
| | - Jan Szatkowski
- Department of Orthopaedic Surgery, Indiana University Health Methodist Hospital, Indianapolis, IN, USA
| | - Derek Moore
- Santa Barbara Orthopedic Associates, Santa Barbara, CA, USA
| | - Jarrad Stevens
- Department of Orthopaedic Surgery, St. Vincent's Hospital, Melbourne, Australia
| |
Collapse
|
3
|
Berlin GW, Fulcher K, Taylor K, Nguyen T, Montiel A, Moore D, Hull M, Lachowsky NJ. Links Between Childhood Abuse, Insidious Trauma, and Methamphetamine Use Across the Lifespan Among Gay, Bisexual, and Other Men Who Have Sex with Men: A Qualitative Analysis. J Homosex 2023; 70:3192-3212. [PMID: 35759650 DOI: 10.1080/00918369.2022.2089075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Developmental and lifespan examinations of methamphetamine use among gay, bisexual, and other men who have sex with men (GBM) remain limited. We used a feminist trauma framework to examine potential links between childhood trauma, trauma-related stressors, and methamphetamine use among GBM. From June 2018 to October 2018, semi-structured interviews (N = 33) were conducted with GBM across British Columbia. Interviews focused on sexual experiences, support services, and methamphetamine use. Using thematic analysis, two overarching trauma-related themes were identified: developmental and insidious trauma and coping with trauma-related stressors. GBM's methamphetamine use co-occurred with childhood experiences of family- and peer-perpetrated heterosexism, childhood sexual abuse, and intersecting forms of oppression/marginalization. These experiences manifested as internalized shame, interpersonal anxiety, and low self-esteem. In adulthood, participants reported difficulty managing emotions, low self-confidence, and loneliness. GBM reported using methamphetamine to manage negative emotions, life stressors, and overcome barriers to interpersonal connection. Findings indicate a need for trauma-informed interventions that address underlying issues and help GBM cultivate supportive relationships.
Collapse
Affiliation(s)
- G W Berlin
- School of Public Health & Social Policy, University of Victoria, Victoria, British Columbia, Canada
- Department of Psychology, Toronto Metropolitan University, Toronto, Ontario, Canada
| | - K Fulcher
- School of Public Health & Social Policy, University of Victoria, Victoria, British Columbia, Canada
| | - K Taylor
- School of Public Health & Social Policy, University of Victoria, Victoria, British Columbia, Canada
- Canadian Institute of Substance Use Research, University of Victoria, Victoria, British Columbia, Canada
| | - T Nguyen
- Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - A Montiel
- School of Public Health & Social Policy, University of Victoria, Victoria, British Columbia, Canada
| | - D Moore
- Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - M Hull
- Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
| | - N J Lachowsky
- School of Public Health & Social Policy, University of Victoria, Victoria, British Columbia, Canada
- CIHR Canadian HIV Trials Network, Vancouver, British Columbia, Canada
| |
Collapse
|
4
|
Cozannet P, Jlali M, Moore D, Archibeque M, Preynat A. Evaluation of phytase dose effect on performance, bone mineralization, and prececal phosphorus digestibility in broilers fed diets with varying metabolizable energy, digestible amino acids, and available phosphorus concentration. Poult Sci 2023; 102:102755. [PMID: 37245439 DOI: 10.1016/j.psj.2023.102755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2023] [Revised: 04/18/2023] [Accepted: 04/24/2023] [Indexed: 05/30/2023] Open
Abstract
The nutritional composition of diets and the provision of exogenous phytases play important roles in animal performance. Therefore, we evaluated the individual and combined impact of metabolizable energy (ME), digestible lysine (dLys), available phosphorus (avP) and calcium (Ca), and phytase dose (1,000 or 2,000 FTU/kg) on the growth performance, feed efficiency, phosphorus digestibility, and bone ash content of broiler chickens from 10 to 42 d of age. Experimental diets were formulated in a Box-Behnken design to contain various levels of ME (11.9, 12.2, 12.54, or 13.1 MJ/kg), dLys (0.91, 0.93, 0.96, or 1.00%) and avP/Ca (0.12/0.47, 0.21/0.58, or 0.33/0.68%). The effect of phytase was expressed in terms of the extra nutrients released. The diets were formulated to have consistent phytate substrate contents (0.28% in average). Body weight gain (BWG) and feed conversion ratio (FCR) were described via polynomial equations (R2 = 0.88 and 0.52, respectively), with interconnections between variables (ME, dLys, and avP/Ca). No interaction was observed among variables (P > 0.05). Metabolizable energy was the most important factor affecting BWG and FCR (linearly; P < 0.001). Reducing ME content from 13.1 to 11.9 MJ/kg in control diet resulted in a 6.8% decrease in BWG and a 3.1% increase in FCR (P < 0.001). The dLys contents also affected performance linearly (P < 0.001), but to a lesser degree; BWG decreased by 160 g when the dLys was reduced by 0.09% units, while the same reduction in dLys increased the FCR by 0.108 points. The inclusion of phytase alleviated the negative effects on feed intake (FI), BWG, and FCR. Phytase improved phosphorus digestibility and bone ash content according to a quadratic relationship. When phytase was added, ME negatively affected FI (r = -0.82, P < 0.001), whereas the dLys content was correlated with FCR (r = -0.80, P < 0.001). Supplementing phytase allowed the reduction of ME, dLys, and avP-Ca in the diet without affecting performance. The addition of phytase increased of ME, dLys, and avP by 0.20 MJ/kg, 0.04 and 0.18% units for 1,000 FTU/kg and 0.4 MJ/kg, 0.06 and 0.20% units for 2,000 FTU/kg.
Collapse
Affiliation(s)
- P Cozannet
- Adisseo France SAS, Center of Expertise in Research and Nutrition, 03600 Malicorne, France.
| | - M Jlali
- Adisseo France SAS, Center of Expertise in Research and Nutrition, 03600 Malicorne, France
| | - D Moore
- Colorado Quality Research, INC, Wellington, CO 80549, USA
| | - M Archibeque
- Colorado Quality Research, INC, Wellington, CO 80549, USA
| | - A Preynat
- Adisseo France SAS, Center of Expertise in Research and Nutrition, 03600 Malicorne, France
| |
Collapse
|
5
|
Paredes JL, Picon V, Reynolds L, Ugarte-Gil C, Moore D. Impact of the COVID-19 pandemic on TB care in Peru. Int J Tuberc Lung Dis 2023; 27:411-413. [PMID: 37143218 DOI: 10.5588/ijtld.22.0621] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023] Open
Affiliation(s)
- J L Paredes
- School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru, TB Centre, London School of Hygiene & Tropical Medicine, London, UK, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - V Picon
- School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - L Reynolds
- TB Centre, London School of Hygiene & Tropical Medicine, London, UK
| | - C Ugarte-Gil
- School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru, TB Centre, London School of Hygiene & Tropical Medicine, London, UK, Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru
| | - D Moore
- School of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru, TB Centre, London School of Hygiene & Tropical Medicine, London, UK
| |
Collapse
|
6
|
Hartnell GF, Lemke S, Moore D, Matthews A, Nemeth MA, Brister R, Liu S, Aulbach C. Performance and health of broiler chickens fed low erucic acid, lower fiber pennycress (CoverCress TM) grain. Poult Sci 2023; 102:102432. [PMID: 36682128 PMCID: PMC10014341 DOI: 10.1016/j.psj.2022.102432] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2022] [Revised: 12/10/2022] [Accepted: 12/13/2022] [Indexed: 12/23/2022] Open
Abstract
CoverCress (low erucic acid, lower fiber pennycress) is being developed as a cover crop to be planted in the fall after corn and harvested in the spring prior to planting soybeans. Two experiments were conducted to evaluate 2 lines of the whole grain (CCWG-1: natural mutation and mutation breeding; CCWG-2: gene edited) and the whole grain pretreated with the potential palatability agent copper sulfate (CCWG-1-CuSO4; CCWG-2-CuSO4) as an ingredient for broilers. In Experiment 1, CCWG-1-CuSO4 was included in the diet at 0, 4, and 6% for 41 d. Feed intake, body weight gain, feed conversion, processing characteristics, organ weights, serum thyroid, macropathology and histology data were collected. In Experiment 2, broilers were fed diets containing Control, 2% CCWG-1, 4% CCWG-1, 4% CCWG-2, and 4.35% CCWG-1-CuSO4 for 42 d. Feed intake, body weight gain, feed conversion, organ weights, serum thyroid, blood chemistries, macropathology, and histology data were collected. In Experiment 1, feed intake and body weight were diminished with no effect on feed conversion for the birds consuming diets containing CCWG-1-CuSO4. In Experiment 2, feed intake and body weight were lower with no difference in feed conversion in birds fed diets containing greater than 2% CoverCress grain during d 0 to 28. During d 28 to 42 no difference in feed intake, body weight and an improvement in feed conversion was observed in birds fed all of the CoverCress grain products. In both experiments no significant negative effects were observed in processing, liver, kidney, and thyroid weights, T3, T4, blood chemistries, macropathology, and histopathology between the control and any of the CoverCress grain treatments. No difference in performance was observed in birds fed the mutant (4% CCWG-1) and gene-edited (4% CCWG-2) products. Pretreating CoverCress grain with copper sulfate did not have a significant effect on improving palatability. In conclusion, CoverCress grain can be safely fed to broilers when included at a target rate of 4% in diets and with total glucosinolate levels not to exceed 4.9 µmoles g-1.
Collapse
Affiliation(s)
- G F Hartnell
- Hartnell International Consulting, LLC, St. Peters, MO 63376, USA.
| | - S Lemke
- SLL Consulting & Services, LLC, St. Louis, MO 63122, USA
| | - D Moore
- Colorado Quality Research Inc., Wellington, CO 80549, USA
| | - A Matthews
- Colorado Quality Research Inc., Wellington, CO 80549, USA
| | - M A Nemeth
- Statistical Consultants Plus, Fenton, MO 63026, USA
| | - R Brister
- Tyson Foods, Springdale, AR 72765, USA
| | - S Liu
- CoverCress Inc., St. Louis, MO 63132, USA
| | - C Aulbach
- CoverCress Inc., St. Louis, MO 63132, USA
| |
Collapse
|
7
|
Nic Iomhair A, Moore D, Hall-Scullin E, Bowes L, Seasman A. The Greater Manchester Child Friendly Dental Practice Scheme: Using a Transformational Commissioning Approach to Align Paediatric Dental Service Provision with Childhood Oral Health Needs in Greater Manchester. Community Dent Health 2022; 39:219-224. [PMID: 36196993 DOI: 10.1922/cdh_00110niciomhair06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
In response to the impact of the COVID-19 pandemic on access to already oversubscribed specialist paediatric dental services, a pilot of an enhanced primary care paediatric dental pathway, known as the Child Friendly Dental Practice (CFDP) scheme, was commissioned by the Greater Manchester Health and Social Care Partnership. Supported by a transformational commissioning approach, the ambition of the CFDP pilot was to manage or stabilise the oral health of high-need paediatric patients who had been referred to specialist dental services within Community or Hospital Dental Service settings, through timely access to primary care clinicians who were confident and experienced in treating children. The theory of change of the CFDP pilot proposed that rapid access to enhanced primary dental care would reduce the need for onward referral to specialist paediatric dental services, whilst also stabilising the oral health of children who require more complex management in specialist services. A formative evaluation of the phase one pilot implementation of the CFDP Scheme has demonstrated the potential of the CFDP Scheme to improve access to dental services for paediatric patients referred from their General Dental Practitioner. Comparison of waiting times between the CFDP pathway and the standard paediatric dental referral pathway have revealed substantially reduced waiting times to access care along the CFDP pathway, while less than 30% of those who attended CFDPs required onward referral to specialist paediatric dental services. Encouragingly, similar attendance and treatment completion rates were noted among patients from all levels of socio-economic deprivation, reducing concerns regarding the potential for service-based interventions to increase oral health inequalities. Following successful completion of the phase one pilot implementation and evaluation, the CFDP Scheme has now been rolled out across all localities in Greater Manchester as part of a second phase pilot implementation. Public Health Competencies; Equitable healthcare provision, Partnership working, Evidence-based public health, Systems thinking, Transformational commissioning, Healthcare evaluation.
Collapse
Affiliation(s)
- A Nic Iomhair
- School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, UK
| | - D Moore
- Dental Health Unit, University of Manchester, UK
| | - E Hall-Scullin
- North West Regional Public Health Group, NHS England and NHS Improvement, UK
| | - L Bowes
- Primary Care Division, Greater Manchester Health & Social Care Partnership, UK
| | - A Seasman
- Primary Care Division, Greater Manchester Health & Social Care Partnership, UK
| |
Collapse
|
8
|
Nyakutsikwa B, Allen T, Walsh T, Pretty I, Birch S, Tickle M, Moore D. Who are the 10%? Characteristics of the populations and communities receiving fluoridated water in England. Community Dent Health 2022; 39:247-253. [PMID: 35946922 DOI: 10.1922/cdh_00092nyakutsikwa07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
OBJECTIVES In England, around 10% of the population receive optimally fluoridated water. This coverage has evolved through a combination of historical local decision-making and natural geography, rather than being strategically targeted at the national level. It is important to understand if the current distribution is equitable according to indicators of oral health need and to identify any population-level differences in socio-demographic characteristics that could introduce bias to studies evaluating the effectiveness of water fluoridation. BASIC RESEARCH DESIGN Descriptive analysis comparing the census characteristics of populations that received optimally fluoridated (=/⟩ 0.7 mg F/L) and non-fluoridated water (⟨0.7 mg F/L) between 2009 and 2020. RESULTS Populations receiving fluoridated water between 2009-2020 were on average slightly younger, more urban, more deprived, with lower education levels, higher unemployment and lower car and home ownership than the populations who received non-fluoridated water. They are more ethnically diverse, with a higher proportion of Asian ethnicity and a lower proportion of White ethnicity, compared to the non-fluoridated population. DISCUSSION This descriptive analysis provides evidence that water fluoridation coverage within England is targeted reasonably equitably in relation to population-level indicators of need. It also confirms the need to consider the impact of underlying differences in age, deprivation, rurality, and ethnicity when evaluating the impact of water fluoridation on health outcomes in England.
Collapse
Affiliation(s)
- B Nyakutsikwa
- Division of Dentistry, The University of Manchester, UK
| | - T Allen
- Manchester Centre for Health Economics, Manchester, UK
| | - T Walsh
- Division of Dentistry, The University of Manchester, UK
| | - I Pretty
- Division of Dentistry, The University of Manchester, UK
| | - S Birch
- Manchester Centre for Health Economics, Manchester, UK
| | - M Tickle
- Division of Dentistry, The University of Manchester, UK
| | - D Moore
- Division of Dentistry, The University of Manchester, UK
| |
Collapse
|
9
|
Hessey S, Pich O, Huebner A, Puttick C, Lombardelli C, Moore D, McGranahan N, Zaccaria S, Swanton C, Jamal-Hanjani M. 2MO Tracking immunoediting from early to late-stage lung cancer. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
10
|
Hynds R, Huebner A, Pearce D, Pich O, Akarca A, Moore D, Ward S, Hill M, Jamal-Hanjani M, Marafioti T, McGranahan N, Swanton C. 3MO Genomic evolution of non-small cell lung cancer during the establishment and propagation of patient-derived xenograft models. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
11
|
Nyakutsikwa B, Walsh T, Pretty I, Moore D. Water fluoride concentrations in England, 2009-2020. Community Dent Health 2022; 39:106-112. [PMID: 34982862 DOI: 10.1922/cdh_00267nyakutsikwa07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVES Contemporary research, surveillance and monitoring of water fluoridation requires an understanding of the population coverage of this intervention. The aims of this research are to create the first publicly available record of water fluoride concentrations in England and to describe and visualise the observed variation in water fluoride concentrations and optimal fluoridation (⟩/= 0.7 mg F/L) between 2009-2020. BASIC RESEARCH DESIGN Routine water quality sampling data were requested from water companies in England from 2009-2020 under the provisions of the Environmental Information Regulations 2004. Fluoride concentrations of Water Supply Zones (WSZs) were assigned to Lower Super Output Areas (LSOAs) using population-weighted centroids. RESULTS Between 2009-2020 4247 LSOAs (12.9%) had an annual mean water fluoride concentration of ⟩/= 0.7 mg F/L in at least one year, and 3019 LSOAs (9.1%) had a grand mean fluoride concentration of ⟩/= 0.7 mg F/L. Coverage of optimal fluoridation varied over time; from 10.9% of LSOAs in 2014 to 6.3% in 2016. DISCUSSION This study confirms previous work identifying variability in the coverage and achieved concentrations of water fluoridation programmes. The current provision for accessing, collating and utilising these data are a barrier to essential monitoring, surveillance and research. An annually maintained and publicly accessible database of water fluoride concentrations is urgently required.
Collapse
Affiliation(s)
- B Nyakutsikwa
- Division of Dentistry, The University of Manchester, UK
| | - T Walsh
- Division of Dentistry, The University of Manchester, UK
| | - I Pretty
- Division of Dentistry, The University of Manchester, UK
| | - D Moore
- Division of Dentistry, The University of Manchester, UK
| |
Collapse
|
12
|
Treasure AM, Hall SM, Lesko I, Moore D, Sharan M, van Zaanen M, Yehudi Y, van der Walt A. Ten simple rules for establishing a mentorship programme. PLoS Comput Biol 2022; 18:e1010015. [PMID: 35551516 PMCID: PMC9098017 DOI: 10.1371/journal.pcbi.1010015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
In recent years, a wide variety of mentorship programmes targeting issues that cannot be addressed through traditional teaching and learning methods alone have been developed. Mentoring plays significant roles in the growth and development of both mentors and mentees, and the positive impacts of mentoring have been well documented. Mentorship programmes are therefore increasingly being implemented in a wide variety of fields by organisations, academic institutes, businesses, and governments. While there is a growing body of literature on mentoring and mentorship programmes, gaining a clear overview of the field is often challenging. In this article, we therefore provide a concise summary of recommendations to consider when designing and establishing mentorship programmes. These recommendations are based on the collective knowledge and experiences of 4 different emerging and established mentorship programmes and can be adapted across various mentorship settings or contexts.
Collapse
Affiliation(s)
| | | | - Igor Lesko
- Open Education Global, Concord, Massachusetts, United States of America
| | | | - Malvika Sharan
- Open Life Science, Wimblington, United Kingdom
- The Alan Turing Institute, London, United Kingdom
| | - Menno van Zaanen
- South African Centre for Digital Language Resources, Potchefstroom, South Africa
| | - Yo Yehudi
- Open Life Science, Wimblington, United Kingdom
- Department of Computer Science, University of Manchester, Manchester, United Kingdom
| | | |
Collapse
|
13
|
Moore D, Munshi S. P.191 Cerebral venous thrombosis in pregnancy after spinal and epidural blood patch dural puncture. Int J Obstet Anesth 2022. [DOI: 10.1016/j.ijoa.2022.103487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Murray P, O'Connor CT, Maher V, Moore D. Opportunities for Education in Heart Failure Pharmacotherapy Demonstrated by a Survey of Clinicians. Ir Med J 2022; 115:577. [PMID: 35695672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Aim We conducted a survey of practitioners' knowledge of the clinical application of the major drug classes in HF, with reference to the European Society of Cardiology guidelines. The aim was to identify areas for practice development through education, which may improve HF morbidity and mortality. Methods We distributed a 14 item questionnaire assessing doctors knowledge of indications and contraindications for the major HF drug classes. Results Total number of responses was 127: Intern (N=21), SHO (N=64), Registrar (N=12), SpR (N=14), Consultant (N=4), GP (N=2). Consultants and GPs were excluded from analysis due to underrepresentation. Median years of practice was 4. Indications were correctly identified in a mean of 78% of responses overall. Of participants who felt comfortable with initiation and up-titration of beta blockers (N=84), only 31% (N=26) correctly identified an optimal target heart rate of less than 70 beats per minute. Forty-five percent (N=50) identified serum potassium and creatinine concentrations generally considered safe as contraindications to the initiation of MRA. Twenty-five percent of respondents (N=28) were unaware of a specialist HF service that catered to their institution, and how to refer to it, but 99% (N=110) felt that their practice would benefit from further education on HF pharmacotherapy. Conclusion Results of this survey suggest a need, and indeed a demand, for further education for clinicians in order to reduce mortality, morbidity, and hospital readmission in HF, as well as their attendant costs.
Collapse
Affiliation(s)
- P Murray
- Department of Cardiology, Tallaght University Hospital
| | - C T O'Connor
- Department of Cardiology, Tallaght University Hospital
| | - V Maher
- Department of Cardiology, Tallaght University Hospital
| | - D Moore
- Department of Cardiology, Tallaght University Hospital
| |
Collapse
|
15
|
Vanderpont AK, Lobson C, Lu Z, Luong K, Arentsen M, Vera T, Moore D, White MS, Prosser RS, Wong CS, Hanson ML. Fate of thiamethoxam from treated seeds in mesocosms and response of aquatic invertebrate communities. Ecotoxicology 2022; 31:341-356. [PMID: 35000026 DOI: 10.1007/s10646-021-02500-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/23/2021] [Indexed: 06/14/2023]
Abstract
Thiamethoxam is a neonicotinoid insecticide widely applied in the Canadian Prairies. It has been detected in surface waters of agro-ecosystems, including wetlands, but the potential effects on non-target invertebrate communities in these wetlands have not been well characterized. In an effort to understand better the fate of thiamethoxam in wetlands and the response of invertebrates (zooplankton and emergent insects), model systems were used to mimic wetland flooding into planted fields. Outdoor mesocosms were treated with a single application of thiamethoxam-treated canola seeds at three treatment levels based on a recommended seeding rate (i.e., 6 kg/ha; 1×, 10×, and 100× seeding rate) and monitored over ten weeks. The mean half-life of thiamethoxam in the water column was 6.2 d. There was no ecologically meaningful impact on zooplankton abundances or community structure among treatments. Statistically significant differences were observed in aquatic insect abundance between control mesocosms and the two greatest thiamethoxam treatments (10× and 100× seeding rate). The observed results indicate exposure to thiamethoxam at environmentally relevant concentrations likely does not represent a significant ecological risk to abundance and community structure of wetland zooplankton and emergent insects.
Collapse
Affiliation(s)
- A K Vanderpont
- Department of Environment and Geography, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada
| | - C Lobson
- Department of Environment and Geography, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada
| | - Z Lu
- Institut des Sciences de la Mer de Rimouski, Université du Québec à Rimouski, Rimouski, Québec, G5L 3A1, Canada
| | - K Luong
- Richardson College for the Environment, University of Winnipeg, Winnipeg, MB, Canada
| | - M Arentsen
- Richardson College for the Environment, University of Winnipeg, Winnipeg, MB, Canada
| | - T Vera
- Richardson College for the Environment, University of Winnipeg, Winnipeg, MB, Canada
| | - D Moore
- Department of Environment and Geography, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada
| | - M S White
- EcoMetrix Inc, Mississauga, ON, L5N 2L8, Canada
| | - R S Prosser
- School of Environmental Sciences, University of Guelph, Guelph, ON, N1G 2W1, Canada
| | - C S Wong
- Richardson College for the Environment, University of Winnipeg, Winnipeg, MB, Canada
- Southern California Coastal Water Research Project Authority, Costa Mesa, CA, 92626, USA
| | - M L Hanson
- Department of Environment and Geography, University of Manitoba, Winnipeg, MB, R3T 2N2, Canada.
| |
Collapse
|
16
|
Grewal R, Deeks SL, Hart TA, Cox J, De Pokomandy A, Grennan T, Lambert G, Moore D, Coutlée F, Gaspar M, George C, Grace D, Jollimore J, Lachowsky NJ, Nisenbaum R, Ogilvie G, Sauvageau C, Tan DHS, Yeung A, Burchell AN. Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada's three largest cities. Hum Vaccin Immunother 2021; 17:5413-5425. [PMID: 34856869 DOI: 10.1080/21645515.2021.1979379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
Abstract
BACKGROUND Some Canadian jurisdictions offer publicly funded HPV vaccine to gay, bisexual, and other men who have sex with men (GBM) aged ≤26 years. We characterized factors associated with being in different stages of HPV vaccination. METHODS Engage is a sexual health study of GBM in the three largest Canadian cities recruited via respondent driven sampling (RDS). We categorized participants as: (1) unaware of HPV vaccine, (2) undecided/unwilling to get vaccinated, (3) willing to get vaccinated, (4) vaccinated with one or more doses. Our RDS-II weighted analyses used multinomial logistic regression to identify factors associated with being in earlier stages of the cascade compared to Stage 4. RESULTS Across the cities, 26-40%, 7-14%, 33-39%, and 13-28% were in Stages 1 to 4, respectively. Compared to Stage 4, being in earlier stages of the cascade was associated with bisexual-identification (Stage 1: adjusted odds ratio[aOR] = 2.84, 95% confidence interval[CI] = 1.06-7.62; Stage 2: aOR = 3.09, 95%CI = 1.19-8.05), having immigrated to Canada (Stage 1: aOR = 1.79, 95%CI 1.07-2.99), preference to keep same-sex romantic relationships private (Stage 1: aOR = 1.25, 95% CI = 1.05-1.48; Stage 2: aOR = 1.24, 95%CI = 1.05-1.46), not receiving sexual health information (Stage 1: aOR = 0.31, 95% CI = 0.13-0.71; Stage 2: aOR = 0.27, 95%CI = 0.12-0.64), not accessing a health-care provider (Stage 2: aOR = 0.36, 95%CI = 0.15-0.83), and no past hepatitis A/B vaccination (Stage 1: aOR = 0.16, 95% CI = 0.09-0.30; Stage 2: aOR = 0.18, 95%CI = 0.09-0.35; Stage 3: aOR = 0.38, 95%CI = 0.21-0.61). DISCUSSION Interventions are needed to reduce social and financial barriers, increase sexual health knowledge, and improve GBM-competent health-care access to increase vaccine uptake among GBM.
Collapse
Affiliation(s)
- R Grewal
- MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - S L Deeks
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.,Nova Scotia Department of Health and Wellness, Halifax, Canada
| | - T A Hart
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.,Department of Psychology, Ryerson University, Toronto, Canada
| | - J Cox
- Department of Epidemiology, Biostatistics, and Occupational Health, School of Population and Global Health, Montréal, McGill University.,Direction régionale de santé publique, CIUSSS-Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada
| | - A De Pokomandy
- Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Montréal, Canada
| | - T Grennan
- BC Centre for Disease Control, Provincial Health Services Authority, Vancouver, Canada.,Department of Medicine, University of British Columbia, Vancouver, Canada
| | - G Lambert
- Direction régionale de santé publique, CIUSSS-Centre-Sud-de-l'Île-de-Montréal, Montréal, Canada
| | - D Moore
- Department of Medicine, University of British Columbia, Vancouver, Canada.,BC Centre for Excellence in HIV/AIDS, Vancouver, Canada
| | - F Coutlée
- Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Canada.,Department of Microbiology and Immunology, Université de Montréal, Montréal, Canada
| | - M Gaspar
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - C George
- Department of Exercise, Health, and Sport Sciences, University of Maine, Portland, USA
| | - D Grace
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
| | - J Jollimore
- Community-Based Research Centre, Vancouver, Canada
| | - N J Lachowsky
- BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.,Community-Based Research Centre, Vancouver, Canada.,School of Public Health and Social Policy, University of Victoria, Victoria, Canada
| | - R Nisenbaum
- MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.,Applied Health Research Centre, Unity Health Toronto, Toronto, Canada
| | - G Ogilvie
- BC Centre for Disease Control, Provincial Health Services Authority, Vancouver, Canada.,School of Population and Public Health, University of British Columbia, Vancouver, Canada
| | - C Sauvageau
- Faculty of Medicine, Université Laval, Québec City, Canada.,Institut National de santé publique du Québec, Québec, Canada
| | - D H S Tan
- MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Canada.,Department of Medicine, University of Toronto, Toronto, Canada
| | - A Yeung
- MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Canada
| | - A N Burchell
- MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, Canada.,Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.,Department of Family and Community Medicine, University of Toronto, Toronto, Canada
| |
Collapse
|
17
|
Foster K, Jaswaney R, Moore D, Andy-Nweye A, Mahdavinia M. A032 LATINOS EXPERIENCE LONGER DURATION OF UNCONTROLLED ASTHMA AFTER COVID INFECTION. Ann Allergy Asthma Immunol 2021. [PMCID: PMC8566856 DOI: 10.1016/j.anai.2021.08.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
18
|
Murray P, O'Connor C, Maher V, Moore D. Opportunities for clinician education in the pharmacotherapy of stable heart failure. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0894] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Heart failure (HF) is a commonly encountered clinical entity in the developed world, and is estimated to cost 660m euro annually to the Irish exchequer. Evidence supporting the benefit of multi disciplinary care in reduction of readmission rates has prompted the establishment of specialist HF clinics, resulting in improved medication adherence and early recognition and treatment of mild decompensation, thus averting the need for hospital admission. In contrast, the role of the hospital generalist and the general practitioner in the management of stable HF is under-emphasised despite evidence that optimal medical therapy reduces readmission and its attendant costs. The aim of this survey was to assess knowledge of pharmacotherapeutic options amongst generalists, and identify opportunities for education, in order to further optimise guideline-directed medical therapy while the patient awaits specialist input.
Methods
We distributed a 14 item questionnaire regarding indications for HF medications (as per ESC guidelines) to doctors in medicine and general practice throughout Ireland.
Results
There were 127 responses from 27 centres (117 analysed). Median years of practice was 4. Table 1 depicts the breakdown of clinicians who correctly identified HFrEF as an indication for each of the major drug classes. More than 20% of clinicians at all grades failed to identify HFrEF as an indication for beta blocker therapy. There was a higher level of knowledge amongst junior doctors in the prescription of mineralocorticoid receptor antagonists (p≤0.05) but no statistical difference in knowledge of other drug classes. Only 26% of participants who felt comfortable with initiation and up-titration of beta blockers (N=89) correctly identified an optimal target heart rate of less than 70 beats per minute. Twenty-four percent of respondents (N=28) were unaware of a specialist HF service that catered to their institution. Ninety-seven percent (N=113) felt that their practice would benefit from further education on HF pharmacotherapy.
Conclusion
The high prevalence of HF in Ireland and costs associated with admission for decompensation necessitates a sound knowledge of its management amongst generalists. Results of this survey suggest a need, and indeed a demand, for further education and support surrounding pharmacotherapy of stable heart failure.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Murray
- Tallaght University Hospital, Dublin, Ireland
| | | | - V Maher
- Tallaght University Hospital, Dublin, Ireland
| | - D Moore
- Tallaght University Hospital, Dublin, Ireland
| |
Collapse
|
19
|
Suleiman S, Coughlan J, Waters M, Collins R, Moore D. Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Direct-acting oral anticoagulants (DOACs) are the preferred agents for stroke prevention in patients with non-valvular atrial fibrillation (AF). DOACs may require dose adjustment based on several factors, including: age, renal function and body weight. An inappropriate DOAC prescription is defined as a deviation of the drug specific recommended dose as mentioned in the summary of product characteristics. Inappropriate DOAC prescription may consist of both under- and over-dosing, potentially exposing patients to harm. Therefore, we carried out the current study, with the aim of defining the prevalence and predictors of inappropriate DOAC prescription on first attendance of patients at a specialist AF clinic.
Methods
We performed a retrospective analysis of the clinical database associated with a dedicated AF clinic in a large Irish hospital from August 2015 to March 2020. All new patients who were referred to the clinic and prescribed a DOAC prior to attendance were included. Data collected on patients included demographic and biochemical data in addition to clinical information on medical co-morbidities. In addition, the CHADS2VASc and HASBLED score was calculated for all patients. A multivariable logistic regression model was developed to assess for predictors of inappropriate DOAC dosing. Purposeful variable selection was used with univariate regression performed initially in order to identify predictors to include in the multivariable model.
Results
We included 367 patients in the analysis. An inappropriate DOAC dose was identified in 47 of 367 patients (12.8%). The majority of inappropriate DOAC doses were due to under-dosing (76.6%). Patients prescribed an inappropriate DOAC dose tended to be older (78.9±8.4 vs 69.0±10.5 years, p<.001), with higher creatinine (108.5±4.6 vs 88.9±1.3, p<.001). Patients prescribed an inappropriate DOAC dose also tended to have higher CHADS2VASc (3.8±1.7 vs 3.0±1.5, p=.001) and HASBLED scores (2.0±1.0 vs 1.6±1.0, p=.01) than patients prescribed an appropriate DOAC dose. DOAC choice did not differ between the inappropriate and appropriate DOAC dose groups. On univariate logistic regression analysis, several predictors of inappropriate DOAC prescription were identified, including age, renal function, history of falls, CHADS2VASc score and HASBLED score. However, in the multivariate logistic regression model, only increasing age (p<0.001) and decreasing renal function (p<0.001) remained significant predictors of inappropriate DOAC prescription.
Conclusions
Over one in eight patients (12.8%) are prescribed an inappropriate DOAC dose on first attendance at a dedicated atrial fibrillation clinic. In the majority of cases, the inappropriate DOAC prescription was secondary to under-dosing. In our multivariable, logistic regression model, increasing age and decreasing renal function were significant predictors of inappropriate DOAC prescription.
Funding Acknowledgement
Type of funding sources: None. Table 1
Collapse
Affiliation(s)
- S Suleiman
- Tallaght University Hospital, Department of Cardiology, Dublin, Ireland
| | - J.J Coughlan
- German Heart Centre Munich, Department of Cardiology, Munich, Germany
| | - M Waters
- Tallaght University Hospital, Department of Cardiology, Dublin, Ireland
| | - R Collins
- Tallaght University Hospital, Department of Geriatrics and Stroke Medicine, Dublin, Ireland
| | - D Moore
- Tallaght University Hospital, Department of Cardiology, Dublin, Ireland
| |
Collapse
|
20
|
Grewal R, Deeks SL, Hart TA, Cox J, De Pokomandy A, Grennan T, Lambert G, Moore D, Brisson M, Coutlée F, Gaspar M, George C, Grace D, Jollimore J, Lachowsky NJ, Nisenbaum R, Ogilvie G, Sauvageau C, Tan DHS, Yeung A, Burchell AN. Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019. Vaccine 2021; 39:3756-3766. [PMID: 34074547 DOI: 10.1016/j.vaccine.2021.05.031] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Revised: 03/26/2021] [Accepted: 05/11/2021] [Indexed: 01/21/2023]
Abstract
INTRODUCTION In 2015/2016, Canada's largest provinces implemented publicly-funded human papillomavirus (HPV) vaccination programs for gay, bisexual, and other men who have sex with men (GBM) ≤ 26 years old. We sought to describe HPV vaccine uptake among GBM and determine barriers and facilitators to vaccine initiation with a focus on healthcare access and utilization. METHODS Engage is a cohort study among GBM aged 16 + years in three Canadian cities recruited from 2017 to 2019 via respondent driven sampling (RDS). Men completed a comprehensive questionnaire at baseline. By publicly-funded vaccine eligibility (≤26 years old = eligible for vaccination, ≥27 years old = ineligible), we described HPV vaccine uptake (initiation = 1 + dose, completion = 3 doses) and explored factors associated with vaccine initiation using Poisson regression. All analyses were weighted with the RDS-II Volz-Heckathorn estimator. RESULTS Across the three cities, 26-35% and 14-21% of men ≤ 26 years and 7-26% and 2-9% of men ≥ 27 years initiated and completed HPV vaccination, respectively. Vaccine initiation was significantly associated with STI/HIV testing or visiting a HIV care specialist in the past six months (≤26: prevalence ratio[PR] = 2.15, 95% confidence interval[CI] 1.06-4.36; ≥27: PR = 2.73, 95%CI 1.14-6.51) and past hepatitis A or B vaccination (≤26: PR = 2.88, 95%CI 1.64-5.05; ≥27: PR = 2.03, 95%CI 1.07-3.86). Among men ≥ 27 years old, vaccine initiation was also positively associated with accessing PrEP, living in Vancouver or Toronto, but negatively associated with identifying as Latin American and increasing age. Vaccine initiation was twice as likely among men ≥ 27 years with private insurance versus no insurance. CONCLUSIONS Sixty-five to 74% of men eligible for publicly-funded vaccine across the three cities remained unvaccinated against HPV by 2019. High vaccine cost may partly explain even lower uptake among men ≥ 27 years old. Men seeking sexual health care were more likely to initiate vaccination; bundling vaccination with these services may help improve HPV vaccine uptake.
Collapse
Affiliation(s)
- R Grewal
- Unity Health Toronto, Canada; University of Toronto, Canada
| | - S L Deeks
- University of Toronto, Canada; Public Health Ontario, Canada
| | - T A Hart
- University of Toronto, Canada; Ryerson University, Canada
| | - J Cox
- McGill University, Canada; Direction régionale de santé publique - Montréal, Canada
| | | | - T Grennan
- BC Centre for Disease Control, Canada; University of British Columbia, Canada
| | - G Lambert
- Direction régionale de santé publique - Montréal, Canada
| | - D Moore
- University of British Columbia, Canada; BC Centre for Excellence in HIV/AIDS, Canada
| | | | - F Coutlée
- Centre de recherche du Centre hospitalier de l'Université de Montréal, Canada; Université de Montréal, Canada
| | | | - C George
- University of Southern Maine, United States
| | - D Grace
- University of Toronto, Canada
| | | | - N J Lachowsky
- BC Centre for Excellence in HIV/AIDS, Canada; Community-Based Research Centre, Canada; University of Victoria, Canada
| | - R Nisenbaum
- Unity Health Toronto, Canada; University of Toronto, Canada
| | - G Ogilvie
- BC Centre for Disease Control, Canada; University of British Columbia, Canada
| | - C Sauvageau
- Université Laval, Canada; Institut national de santé publique du Québec, Canada
| | - D H S Tan
- Unity Health Toronto, Canada; University of Toronto, Canada
| | - A Yeung
- Unity Health Toronto, Canada
| | - A N Burchell
- Unity Health Toronto, Canada; University of Toronto, Canada.
| |
Collapse
|
21
|
Balfe C, Jacob B, Hickey N, Moore D, Mulcahy D, Loo B. Exploring diastolic pressure ratio to fractional flow reserve discordance and a hypothesis on tailoring diastolic pressure ratio cut-off values to improve diagnostic accuracy in the mid- and distal-LAD. Int J Cardiol Heart Vasc 2021; 34:100784. [PMID: 33997257 PMCID: PMC8105297 DOI: 10.1016/j.ijcha.2021.100784] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2020] [Revised: 03/27/2021] [Accepted: 04/07/2021] [Indexed: 11/19/2022]
Abstract
This study assessed diastolic pressure ratio to FFR discordance. 12.7% of LAD lesions in this study had discordant result. 2.4% of non-LAD lesions had discordant results. This represents a statistically significant difference in discordance rate.
Previous studies have identified a higher rate of discordance between non-hyperaemic pressure ratios and FFR in the LAD when compared to the other two coronary arteries. We hypothesised that in keeping with recently published data, we would identify a higher discordance rate between diastolic pressure ratio (DPR) and FFR in the LAD compared to the RCA or LCx. In our study, 12.7% of LAD lesions had discordant results compared with 2.4% of non-LAD lesions. This represents a statistically significant increased rate of discordance in LAD lesions compared to non-LAD lesions (p = 0.04986). Note was made of a tendency for non-proximal LAD lesions to be associated with false-positive DPR results in the borderline range (0.88 and 0.89). In a speculative, hypothesis generating post-hoc analysis, we found an improved diagnostic accuracy of DPR when the cut-off value for a positive DPR in the non-proximal LAD was changed to ≤0.87. It is fathomable that improvements in the diagnostic accuracy of DPR for FFR may be improved by tailoring DPR cut-offs to the location of the lesion assessed.
Collapse
Affiliation(s)
- C Balfe
- Tallaght University Hospital, Ireland
| | - B Jacob
- Victoria Hospital, Kirkcaldy, United Kingdom
| | - N Hickey
- Tallaght University Hospital, Ireland
| | - D Moore
- Tallaght University Hospital, Ireland
| | - D Mulcahy
- Tallaght University Hospital, Ireland
| | - B Loo
- Tallaght University Hospital, Ireland
| |
Collapse
|
22
|
TEH J, Soh B, Selvarajah L, Moore D, Moloney B, O'Hara P, Casserly L. POS-347 PREVALENCE OF POLYCYSTIC KIDNEY DISEASE IN THE MID WEST OF IRELAND AND CANDIDACY FOR TOLVAPTAN THERAPY. Kidney Int Rep 2021. [DOI: 10.1016/j.ekir.2021.03.363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
23
|
Holland DE, Vanderboom CE, Dose AM, Moore D, Robinson KV, Wild E, Stiles C, Ingram C, Mandrekar J, Borah B, Taylor E, Griffin JM. Death and Grieving for Family Caregivers of Loved Ones With Life-Limiting Illnesses in the Era of COVID-19: Considerations for Case Managers. Prof Case Manag 2021; 26:53-61. [PMID: 33181608 PMCID: PMC8270010 DOI: 10.1097/ncm.0000000000000485] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Purpose: Family caregivers of a loved one with a life-limiting or terminal illness are often overwhelmed by, and underprepared for, their responsibilities. They often need help from family members and friends to provide comprehensive care. When death occurs, funerals and other death-related rituals bring family and communities together to honor the life and mourn the death of a loved one and provide needed support to family and caregivers. These collective rituals are often deeply rooted in culturally-bound values and can facilitate grief and help make sense about loss. Rituals act as bridge-building activities that allow people to organize and appraise emotions, information, and actions after a loss. With the emergence of the coronavirus disease-2019 (COVID-19) pandemic and the recommended restrictions to reduce infection and transmission, family members and caregivers are often faced with weighing options for honored rituals to help them grieve. Grieving during the pandemic has become disorganized. The purpose of this article is to provide case managers and other clinical staff with recommendations on guiding caregivers/families through safety precautions when a loved one dies either because of a life-limiting illness or from COVID-19 during the pandemic using guidelines from the Centers for Disease Control and Prevention (CDC). The authors also present information about complicated grief and ways to support coping with death and suggest safe alternatives to traditional death-related rituals and funerals in a COVID-19 era. Primary Practice Setting(s): Primary practice settings include home health care, hospice, hospital discharge planning, case management, and primary care. Findings/Conclusions: Precautions necessary in a COVID-19 era may add anxiety and stress to an already difficult situation of caring for loved ones at end-of-life and grieving with their loss. Utilization of CDC guidelines lessens the risk of infection while honoring loved ones’ wishes and cultural traditions surrounding death and burial. Recognition of social and spiritual connections that comfort mourners must also be considered.
Collapse
Affiliation(s)
- Diane E Holland
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Catherine E Vanderboom
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Ann Marie Dose
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Derek Moore
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Kelly V Robinson
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Ellen Wild
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Carole Stiles
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Cory Ingram
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Jay Mandrekar
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Bijan Borah
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Erin Taylor
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| | - Joan M Griffin
- Diane E. Holland, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on improving the transitions of adult patients from the hospital to the community and includes identifying early in the hospital stay patients who will benefit from specialized discharge planning resources
- Catherine E. Vanderboom, PhD, RN, is a researcher at the Mayo Clinic, Rochester, Minnesota. Her research is focused on community-based interventions to assist adults with chronic health conditions and caregivers providing at end-of-life care
- Ann Marie Dose, PhD, RN, is a researcher and palliative care nurse at the Mayo Clinic, Rochester, Minnesota. Her program of research is focused on psychosocial interventions for individuals facing the end-of-life and their families
- Derek Moore, MPH, MN, RN, is a PhD candidate at the University of Minnesota, School of Nursing, with his research area of focus in hospice and palliative home-based care. He has worked as an RN in both long-term and home care settings, in addition to previously serving as an epidemiologist for a county health department
- Kelly V. Robinson, BA, RN , is a nurse care coordinator for Westat Research supporting research participants through Rise, Inc. She is also President of Black Nurses Rock-Twin Cities Chapter. She began her career in Atlanta, Georgia. Kelly has 26 years of nursing experience including postoperative care, orthopedics, oncology, pain management, operating room, and behavioral health
- Ellen Wild, RN, CHPN , is a certified palliative care and hospice nurse. Her current role is as the intervention nurse for the Technology-enhanced Transitional Palliative Care for Family Caregivers in Rural Settings study. She is a certified hospice and palliative care nurse
- Carole Stiles, MSW, LICS, is a clinical social worker whose current focus of work is with hospice and palliative care. She previously served as Director of Social Work, Mayo Clinic, Rochester, Minnesota
- Cory Ingram, MD , is a consultant physician faculty member in the Center for Palliative Medicine at Mayo Clinic serving as the Medical Director for SEMN with research and quality improvement efforts focused on the delivery of palliative medicine to patients and families across various settings
- Jay Mandrekar, PhD , is a biostatistician with research interests in applications of statistical techniques to clinical trials, retrospective studies, etc. He works with diverse groups of researchers, which include nurse scientists, clinicians, surgeons, laboratory scientists, and other data scientists
- Bijan Borah, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. He also leads the Economic Evaluation Service Program at the Kern Center for the Science of Health Care Delivery. His research focus is in the area of comparative effectiveness research
- Erin Taylor, MSW, LICSW, is a Social Worker on the Technology-Enhanced Family Caregiver Study. Her prior work experiences include nursing home social work, hospice, mental health, and addictions
- Joan M. Griffin, PhD, is a Professor of Health Services Research, Mayo Clinic College of Medicine, Rochester, Minnesota. She studies how to engage caregivers to improve transitions in care, assure care recipient's safety, health outcomes, and quality of life, all while reducing the health risks associated with caregiving
| |
Collapse
|
24
|
Kapil A, Moore D, Bernstein J, Mahdavinia M. A071 SERUM IL-6 LEVELS IN PATIENTS WITH ASPIRIN-EXACERBATED RESPIRATORY DISEASE. Ann Allergy Asthma Immunol 2020. [DOI: 10.1016/j.anai.2020.08.057] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
25
|
Benasson I, Wagnac E, Diotalevi L, Moore D, Mac-Thiong JM, Petit Y. Gait analysis of a post induced traumatic spinal cord injury porcine model. Annu Int Conf IEEE Eng Med Biol Soc 2020; 2020:3803-3806. [PMID: 33018829 DOI: 10.1109/embc44109.2020.9175280] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Porcine model constitutes a potential translational model to study traumatic spinal cord injuries (TSCI) considering its recent use in numerous studies. Recovery of the animal is currently monitored through a qualitative evaluation of the gait. Adding a quantitative evaluation might help to better assess the functional recovery of the animal. In this study, a new controlled method involving the use of an electro-magnetic actuator was used on a pig to induce a TSCI. Chronic monitoring was done using a quantitative analysis of the gait. Results show both, the injury of the pig and its functional recovery. This large animal model will help to provide a better understanding of injury and recovery mechanisms and thus could constitute a strong preclinical model for future therapeutic studies.Clinical Relevance- Methodology and results from this study would provide a better insight on the functional recovery after traumatic spinal cord injuries.
Collapse
|
26
|
Moore D, Young CJ. A systematic review and meta-analysis of biofeedback therapy for dyssynergic defaecation in adults. Tech Coloproctol 2020; 24:909-918. [PMID: 32372153 DOI: 10.1007/s10151-020-02230-9] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2020] [Accepted: 04/18/2020] [Indexed: 02/07/2023]
Abstract
BACKGROUND Dyssynergic defaecation is a common form of functional constipation that responds poorly to conservative interventions. This systematic review and meta-analysis assesses the effectiveness of biofeedback therapy for dyssynergic defaecation using global clinical improvement as the primary outcome, and resolution of the dyssynergic pattern on anorectal physiology and quality of life as secondary outcomes. METHODS MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, Scopus, and Web of Science were searched from inception to March 2019 using a predefined strategy. Randomised controlled trials of adult patients with dyssynergic defaecation and a biofeedback treatment arm were eligible for review. Studies including patients with secondary forms of constipation were excluded. Data abstraction and risk of bias assessments were conducted by consensus between two authors. RESULTS Eleven trials including 725 participants were included in the narrative review. Sixty-three percent of patients treated with biofeedback reported clinical improvement. Six studies included in the meta-analysis showed biofeedback superior to non-biofeedback therapy for the primary outcome (OR 3.63, CI 1.10-11.93, p = 0.03). Heterogeneity between trials and overall risk of bias was high. CONCLUSIONS Biofeedback therapy is recommended for patients referred to tertiary units with dyssynergic defaecation who fail conservative therapy. Future research should be directed towards identifying validated outcomes and the optimum method for delivering biofeedback therapy. Home biofeedback therapy may improve accessibility and recruitment to future clinical trials.
Collapse
Affiliation(s)
- D Moore
- Department of Colorectal Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia
| | - C J Young
- Department of Colorectal Surgery, Royal Prince Alfred Hospital, Camperdown, NSW, 2050, Australia. .,Department of Surgery, The University of Sydney, Sydney, NSW, Australia. .,RPAH Medical Centre, Suite G07/100 Carillon Ave, Newton, NSW, 2042, Australia.
| |
Collapse
|
27
|
Moore D, Drey N, Ayers S. A meta-synthesis of women's experiences of online forums for maternal mental illness and stigma. Arch Womens Ment Health 2020; 23:507-515. [PMID: 31646392 DOI: 10.1007/s00737-019-01002-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/12/2019] [Accepted: 09/11/2019] [Indexed: 11/24/2022]
Abstract
Perinatal mental illness affects 15% of women; however, only half of these women access treatment. Some women with untreated perinatal mental illness may continue to suffer with mental illness after the perinatal period. Evidence suggests that one barrier to accessing treatment is stigma. Forums may provide an acceptable place for women to converse about the stigmatised symptoms of maternal mental illness. Reducing stigma may increase treatment uptake. This study aimed to review and synthesise the qualitative research on maternal mental illness forums and stigma so that stigma can be addressed and treatment improved. A meta-synthesis was conducted to describe and interpret qualitative studies regarding forum use and maternal mental illness stigma. A systematic search of seven electronic databases and Google Scholar was performed. Additional references were collected through screening references of the identified studies. Five studies were identified that reported women's experiences of online forums for maternal mental illness and stigma. The synthesis identified four key themes: (1) a safe place to talk; (2) virtual support; (3) stigma and identity; and (4) repair of the mother identity. Stigma maybe reduced by forum discourse that reconceptualises what is to be a "good mother" and separates stigma and maternal identity. This synthesis provides a novel and more detailed framework for the stigma of maternal mental illness and forum use. This suggests forums may enable women to explore their dual identity and repair their maternal identity, and this may reduce stigma. Healthcare providers could discuss forum use with their clients.
Collapse
Affiliation(s)
- D Moore
- School of Health Sciences, City, University of London, Northampton Square, London, EC1V 0HB, UK. .,The Open University, Walton Hall, Milton Keynes, UK.
| | - N Drey
- School of Health Sciences, City, University of London, Northampton Square, London, EC1V 0HB, UK
| | - S Ayers
- School of Health Sciences, City, University of London, Northampton Square, London, EC1V 0HB, UK
| |
Collapse
|
28
|
Núñez Amin Dick T, Rocha Santos L, Carneiro S, Moore D, Pestana S, Laerte Boechat J, Lavinas Sayed Picciani B. Investigation of oral atopic diseases: Correlation between geographic tongue and fungiform papillary glossitis. J Stomatol Oral Maxillofac Surg 2020; 122:283-288. [PMID: 32540362 DOI: 10.1016/j.jormas.2020.05.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 09/07/2019] [Revised: 05/15/2020] [Accepted: 05/25/2020] [Indexed: 10/24/2022]
Abstract
INTRODUCTION The correlation between oral lesions and atopy is not new, but few studies have investigated the prevalence of mucosal changes in diseases within the atopic spectrum, leading to conflicting data. Some studies found a possible relationship between geographic tongue, transient lingual papillitis and atopic diseases. AIM To investigate the frequency of geographic tongue and fungiform papillary glossitis in patients with atopic diseases, and its correlation with serum IgE levels and skin test results. MATERIAL AND METHODS The sample was comprised of participants with atopic diseases paired with participants who received negative puncture skin tests. All were submitted to stomatological and medical evaluations, prick test and oral cytopathological. RESULTS The female sex was more numerous in both groups. Mean age was 21 years. A total of 60 diagnoses of atopic diseases were obtained, with allergic rhinitis being the most prevalent. Fungiform papillary glossitis was the most frequent oral lesion in both groups, while geographic tongue was present in 2 cases (2%) in the test group and 2 (2%) in the control group. Atopic patients with fungiform papillary glossitis presented high serum IgE levels. In atopic patients with geographic tongue, the prick test positively identified extracts of Dermatophagoides pteronyssinus (100%) and Dermatophagoides farinae (100%). CONCLUSION Due to the low frequency of geographic tongue lesions found in the study, it is no possible to conclude if that could be an oral manifestation of atopy. However fungiform papillary glossitis is a common alteration in atopic and non-atopic patients and has a relationship with high IgE serum levels. However, the consolidation of this result requires a larger sample size.
Collapse
Affiliation(s)
- T Núñez Amin Dick
- Postgraduate Program in Pathology, School of Medicine, Fluminense Federal University, 303, Marquês do Paraná, 4th floor, 24033-900 Niterói, Rio de Janeiro, Brazil
| | - L Rocha Santos
- Postgraduate Program in Pathology, School of Medicine, Fluminense Federal University, 303, Marquês do Paraná, 4th floor, 24033-900 Niterói, Rio de Janeiro, Brazil
| | - S Carneiro
- Sector of Dermatology, Medical Clinic Department, Rio de Janeiro Federal University, Rio de Janeiro, Brazil
| | - D Moore
- Allergy and Clinical Immunology Service, School of Medicine, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil
| | - S Pestana
- Allergy and Clinical Immunology Service, School of Medicine, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil
| | - J Laerte Boechat
- Allergy and Clinical Immunology Service, School of Medicine, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil
| | - B Lavinas Sayed Picciani
- Postgraduate Program in Pathology, School of Medicine, Fluminense Federal University, 303, Marquês do Paraná, 4th floor, 24033-900 Niterói, Rio de Janeiro, Brazil.
| |
Collapse
|
29
|
Lombard J, Urie N, Garry F, Godden S, Quigley J, Earleywine T, McGuirk S, Moore D, Branan M, Chamorro M, Smith G, Shivley C, Catherman D, Haines D, Heinrichs AJ, James R, Maas J, Sterner K. Consensus recommendations on calf- and herd-level passive immunity in dairy calves in the United States. J Dairy Sci 2020; 103:7611-7624. [PMID: 32448583 DOI: 10.3168/jds.2019-17955] [Citation(s) in RCA: 123] [Impact Index Per Article: 30.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2019] [Accepted: 03/16/2020] [Indexed: 01/29/2023]
Abstract
Passive immunity in calves is evaluated or quantified by measuring serum or plasma IgG or serum total protein within the first 7 d of age. While these measurements inform about circulating concentrations of this important protein, they are also a proxy for evaluating all of the additional benefits of colostral ingestion. The current individual calf standard for categorizing dairy calves with successful passive transfer or failure of passive transfer of immunity are based on serum IgG concentrations of ≥10 and <10 g/L, respectively. This cutoff was based on higher mortality rates in calves with serum IgG <10 g/L. Mortality rates have decreased since 1991, but the percentage of calves with morbidity events has not changed over the same time period. Almost 90% of calves sampled in the USDA National Animal Health Monitoring System's Dairy 2014 study had successful passive immunity based on the dichotomous standard. Based on these observations, a group of calf experts were assembled to evaluate current data and determine if changes to the passive immunity standards were necessary to reduce morbidity and possibly mortality. In addition to the USDA National Animal Health Monitoring System's Dairy 2014 study, other peer-reviewed publications and personal experience were used to identify and evaluate potential standards. Four options were evaluated based on the observed statistical differences between categories. The proposed standard includes 4 serum IgG categories: excellent, good, fair, and poor with serum IgG levels of ≥25.0, 18.0-24.9, 10.0-17.9, and <10 g/L, respectively. At the herd level, we propose an achievable standard of >40, 30, 20, and <10% of calves in the excellent, good, fair, and poor categories, respectively. Because serum IgG concentrations are not practical for on-farm implementation, we provide corresponding serum total protein and %Brix values for use on farm. With one-third of heifer calves in 2014 already meeting the goal of ≥25 g/L serum IgG at 24 h of life, this achievable standard will require more refinement of colostrum management programs on many dairy farms. Implementation of the proposed standard should further reduce the risk of both mortality and morbidity in preweaned dairy calves, improving overall calf health and welfare.
Collapse
Affiliation(s)
- J Lombard
- USDA-Animal and Plant Health Inspection Service-Veterinary Services, Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO 80526-8117.
| | - N Urie
- USDA-Animal and Plant Health Inspection Service-Veterinary Services, Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO 80526-8117
| | - F Garry
- Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523-1678
| | - S Godden
- Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, St. Paul 55108
| | - J Quigley
- Cargill Animal Nutrition, Brookville, OH 45309
| | - T Earleywine
- Land O'Lakes Animal Milk Solutions, Cottage Grove, WI 53527
| | - S McGuirk
- School of Veterinary Medicine, University of Wisconsin, Madison 53706
| | - D Moore
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman 99164
| | - M Branan
- USDA-Animal and Plant Health Inspection Service-Veterinary Services, Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO 80526-8117
| | - M Chamorro
- Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, AL 36849
| | - G Smith
- Department of Population Health and Pathobiology, North Carolina State University, Raleigh 27607
| | - C Shivley
- USDA-Animal and Plant Health Inspection Service-Veterinary Services, Center for Epidemiology and Animal Health, National Animal Health Monitoring System, Fort Collins, CO 80526-8117
| | | | - D Haines
- SCCL, Saskatoon, Saskatchewan, Canada, 57K 6A2
| | - A J Heinrichs
- Department of Animal Science, The Pennsylvania State University, University Park 16802
| | - R James
- Down Home Heifer Solutions, Blacksburg, VA 24060
| | - J Maas
- School of Veterinary Medicine, University of California, Davis 95616
| | - K Sterner
- Sterner Veterinary Clinic P.C., Ionia, MI 48846
| |
Collapse
|
30
|
Zhai H, Moore D, Jamal-Hanjani M. Inactivation of RB1 and histological transformation in EGFR-mutant lung adenocarcinoma. Ann Oncol 2020; 31:169-170. [PMID: 31959334 DOI: 10.1016/j.annonc.2019.12.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2019] [Accepted: 12/12/2019] [Indexed: 01/12/2023] Open
Affiliation(s)
- H Zhai
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
| | - D Moore
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Pathology, University College London Hospitals NHS Foundation Trust, London, UK
| | - M Jamal-Hanjani
- Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
| |
Collapse
|
31
|
O"riordan F, Carton M, Coughlan JJ, Fahy A, Donnelly M, Moore D, Loo B, Maher V. P919 The correlation between cardiac biomarkers and findings on transthoracic echocardiography in the intensive care unit. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
BACKGROUND
Trans-thoracic echo (TTE) is a commonly performed non-invasive investigation for the cardiovascular assessment of critically ill patients in the Intensive Care Unit (ICU). Raised cardiac biomarkers are commonly cited as an indication for TTE, however the significance of these biomarker elevations in the critical care setting is unclear.
PURPOSE
The aim of this study was to describe findings on TTE in an Irish ICU cohort and to determine if there was any correlation between these findings and serum N-terminal pro b-type natiuretic (NT-proBNP) and high sensitivity troponin T (HsTnT) levels.
METHODS
Patients admitted to the ICU and who received a TTE between January 2018 and February 2019 were identified. Based on TTE findings, patients were divided into two groups: ‘Normal group’ and ‘Abnormal group’. For the purpose of this study, minor abnormalities including concentric left ventricular hypertrophy, diastolic dysfunction and hyper-dynamic left ventricular function were included in the Normal group. The Abnormal group included reductions in LV function, regional wall motion abnormalities and significant valvular heart disease. Continuous variables were expressed as medians and interquartile range. The groups were compared using the z-test for continuous variables and fishers exact test for categorical variables, with a p value of < 0.05 considered significant.
RESULTS
There were 358 patients admitted to the ICU during the study period. The mean age was 59.8 ± 17 years and over half of the patients (55%) were male. One hundred and fifteen patients (32%) had a reported TTE, of which 55% were normal and 22% had minor abnormalities (Normal group). The remaining 23% showed significant abnormalities (Abnormal group).
The prevalence of a NT-proBNP result over 4 times the upper limit of normal (>4xULN) was not significantly different between groups (67% in Normal group vs 71% in Abnormal group, Fisher exact test statistic value is 0.7887, p < .05). However a HsTnT value >4xULN was more common in the Abnormal group than the Normal group (73% vs 46%, Fisher exact test statistic value is 0.0231, p < .05). Similarly, Median NT-proBNP did not differ significantly between the groups; (2254pg/mL; IQR: 11,758 in the Normal group vs 6428pg/mL; IQR: 5,789 in the Abnormal group, p = 0.52218) but Median HsTnT level was significantly higher in the Abnormal group than Normal group; (123ng/L ; IQR: 656 vs 51ng/L; IQR: 163.5 ,p = 0.0278).
CONCLUSION
TTE is performed commonly in the ICU, with one-third of ICU admissions receiving a TTE. Over 75% were reported as normal or showing only minor abnormalities. NT-Pro BNP was commonly significantly elevated but did not correlate with the subsequent diagnostic yield of significant abnormalities on echocardiography. HsTnT levels were more commonly significantly raised in patients with abnormal TTE results and the role of troponin in this setting requires further evaluation.
Collapse
Affiliation(s)
- F O"riordan
- Adelaide & Meath Hospital, Cardiology , Dublin, Ireland
| | - M Carton
- Adelaide & Meath Hospital, Cardiology , Dublin, Ireland
| | - J J Coughlan
- Adelaide & Meath Hospital, Cardiology , Dublin, Ireland
| | - A Fahy
- Adelaide & Meath Hospital, Intensive Care Unit, Dublin, Ireland
| | - M Donnelly
- Adelaide & Meath Hospital, Intensive Care Unit, Dublin, Ireland
| | - D Moore
- Adelaide & Meath Hospital, Cardiology , Dublin, Ireland
| | - B Loo
- Adelaide & Meath Hospital, Cardiology , Dublin, Ireland
| | - V Maher
- Adelaide & Meath Hospital, Cardiology , Dublin, Ireland
| |
Collapse
|
32
|
Ashikyan O, Chalian M, Moore D, Xi Y, Pezeshk P, Chhabra A. Evaluation of giant cell tumors by diffusion weighted imaging-fractional ADC analysis. Skeletal Radiol 2019; 48:1765-1773. [PMID: 31001688 DOI: 10.1007/s00256-019-03219-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 03/13/2019] [Accepted: 04/08/2019] [Indexed: 02/02/2023]
Abstract
BACKGROUND A single ADC value is used in clinical practice on multi b-value acquisitions. Low b-value acquisitions are affected by intravoxel incoherent motion, which is dependent on perfusion. Giant cell tumors (GCTs) are known to exhibit early arterial enhancement and low ADC values. Mean, minimum and fractional ADC characteristics of osseous and tenosynovial GCTs are systematically evaluated. METHODS Tenosynovial and osseous GCTs were included. Each lesion was evaluated on conventional MRI and DWI by two musculoskeletal radiologists. ADC was measured by placing an ROI on the most confluent enhancing portion of the lesion. Fractional and best fit ADC calculations were performed using MATLAB software. RESULTS No statistically significant difference was found between tenosynovial and osseous lesions' ADC values. Mean ADC for all lesions was 1.0 × 10-3 mm2/s (SD = 0.2 × 10-3 mm2/s) and minimum ADC was 0.5 × 10-3 mm2/s (SD = 0.3 × 10-3 mm2/s). Average mean ADC value obtained from B50-B400 slope was 1.1 × 10-3 mm2/s (SD = 0.2 × 10-3 mm2/s), and the average mean ADC value obtained from B400-B800 slope was 0.8 × 10-3 mm2/s (SD = 0.1 × 10-3 mm2/s) [p-value <0.01]. CONCLUSION Tenosynovial and osseous GCTs demonstrate similar and low ADC values, which become even lower when using high b-value pairs. Our study also supports the theory of intravoxel incoherent motion that becomes apparent at low b values as related to giant cell tumors, which are known to be hyperperfused.
Collapse
Affiliation(s)
- Oganes Ashikyan
- Department of Radiology, Musculoskeletal Imaging, UT Southwestern Medical Center, 5323 Harry Hines Blvd, E230-C, Dallas, TX, 75390-9316, USA.
| | - M Chalian
- Department of Radiology, Musculoskeletal Imaging, UT Southwestern Medical Center, 5323 Harry Hines Blvd, E230-C, Dallas, TX, 75390-9316, USA
| | - D Moore
- Department of Radiology, Musculoskeletal Imaging, UT Southwestern Medical Center, 5323 Harry Hines Blvd, E230-C, Dallas, TX, 75390-9316, USA
| | - Y Xi
- Department of Radiology, Musculoskeletal Imaging, UT Southwestern Medical Center, 5323 Harry Hines Blvd, E230-C, Dallas, TX, 75390-9316, USA
| | - P Pezeshk
- Department of Radiology, Musculoskeletal Imaging, UT Southwestern Medical Center, 5323 Harry Hines Blvd, E230-C, Dallas, TX, 75390-9316, USA
| | - A Chhabra
- Department of Radiology, Musculoskeletal Imaging, UT Southwestern Medical Center, 5323 Harry Hines Blvd, E230-C, Dallas, TX, 75390-9316, USA.,Department of Orthopedic Surgery, UT Southwestern Medical Center, Dallas, TX, USA
| |
Collapse
|
33
|
Paolillo E, Hussain M, Moore R, Moore D, Heaton R. B-15 Engagement in Cognitively-Demanding Activities in Daily Life is Associated with Neurocognitive Test Performance and Perceived Cognitive Difficulties Among Adults With and Without HIV. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz034.98] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objective
Assessing daily activities is important for understanding how cognitive abilities affect everyday functioning. We evaluated a new measure capturing engagement in cognitively-demanding activities among people with and without HIV, and examined associations with neurocognitive test performance and perceived cognitive difficulties.
Method
Participants included 79 adults (59 HIV+, 20 HIV-) enrolled in studies at UCSD (mean age = 55.1; SD = 13.1). Domain-specific composite scaled scores measured neurocognitive functioning as continuous variables. Demographically-corrected global deficit scores determined neurocognitive impairment. Perceived cognitive difficulties were self-reported via the Everyday Cognition scale (ECog). The newly created, self-report Frequency and Difficulty of Activities Scale (FDAS) measured frequency of engagement in 27 cognitively-demanding activities [0 = Never to 10 = Once a day or more] in the last month. FDAS “total frequency score” sums all frequency ratings. Participants also rated difficulty performing each FDAS activity [0 = Not at all to 10 = Extremely]. FDAS “difficult-activity score” sums frequency ratings only for activities that participants identified as difficult for them (i.e., difficulty rating >75th percentile of sample).
Results
Higher FDAS total frequency scores correlated with better verbal fluency (r = 0.26, p = 0.019) and processing speed (r = 0.24, p = 0.030). Multiple regression revealed a significant interaction between cognitive impairment and frequency of engagement in difficult activities (b = 0.34, 95%CI = 0.18-0.50, p < 0.001), such that higher FDAS difficult-activity scores related to more perceived cognitive difficulties only among cognitively impaired participants.
Conclusion
This study explored use of a new measure of complex daily activities to aid neuropsychological interpretation. Results suggest that effects of neurocognitive impairment on perceived cognitive difficulties may only be apparent if individuals are attempting to perform challenging everyday tasks.
Collapse
|
34
|
Campbell L, Kohli M, Heaton A, Higgins M, Lee E, Kaufmann C, Heaton R, Moore D, Moore R. B-24 Objective and Subjective Sleep Measures are Associated with Neurocognition in Middle-Aged and Older Adults With and Without HIV. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz034.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Objective
Poorer sleep quality is related to worse cognitive functioning in the general population and people living with HIV; however, many studies use self-report sleep questionnaires that rely on retrospective recall. This study aimed to examine the relationship between objective (wrist actigraphy) and subjective sleep quality with neurocognitive functioning.
Method
Eighty-five adults aged 50-74 years with and without HIV (HIV+ n = 53, HIV- n = 32) were recruited from the community and ongoing studies at UC San Diego. Participants completed comprehensive neuropsychological testing assessing global and domain-specific cognition. Participants wore actigraphy watches for 14 nights after neuropsychological testing to objectively assess sleep quality (i.e., total sleep time (TST), efficiency, wake after sleep onset, and sleep fragmentation). The Pittsburgh Sleep Quality Index assessed subjective sleep quality.
Results
After adjusting for demographic variables and use of sleep medications, there were no differences in any sleep quality measures by HIV status (p’s>0.05). In separate adjusted linear regression models, lower sleep efficiency (p = 0.02; 95% CI: -9.5, -1.1) and greater sleep fragmentation (p = 0.02; 95% CI: -0.82, -0.09) were associated with worse learning. Less TST was associated with worse working memory (p = 0.02; 95% CI: -9.2, -0.8). In contrast, worse subjective sleep quality was associated with worse executive function (p < 0.01; 95% CI: -1.18, -0.23) and working memory (p = 0.03; 95% CI: -1.22, -0.07).
Conclusion
Both objective and subjective sleep quality were associated with cognition in both persons with and without HIV; however, subjective and objective sleep quality were associated with different cognitive domains. Therefore, both objective and subjective sleep quality are important health behaviors to assess.
Collapse
|
35
|
Kohli M, Kamalyan L, Pasipanodya E, Moore R, Letendre S, Jeste D, Moore D. C-25 Neurocognitive Correlates of Chronological and Subjective Age Differences in Persons Living with HIV compared to those without HIV. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz034.187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objective
Investigate the discrepancy between subjective and chronologic age by HIV-serostatus, and the association of this discrepancy with subjective neurocognitive functioning (NCF) and objective NCF.
Methods
One hundred nineteen persons living with HIV (PWLH) and 98 HIV-uninfected (HIV-) adults (Mage = 50.9; SDage = 7.9) completed a comprehensive neurobehavioral battery. Subjective age was assessed using a single-item question (i.e., “how old do you feel?”). The difference between chronologic and subjective age resulted in subjective age discrepancy scores (SADS). Subjective NCF was measured using the Patient’s Assessment of Own Functioning Inventory; objective NCF was measured using global demographically-corrected T-scores. Linear regressions examined the association between subjective and objective NCF with SADS, covarying for significant PLWH and HIV- group differences (i.e., education, sex, ethnicity, and lifetime Major Depressive Disorder).
Results
PLWH reported lower SADS (indicating closer correspondence between chronologic and subjective age) than their HIV- counterparts, who reported feeling much younger (p = .05; 95% CI: -5.4, .001). Among PLWH, better subjective NCF was significantly related to greater SADS (p = .0002; 95% CI: -.48, -.16). Objective NCF was not associated with SADS among persons with and without HIV.
Conclusions
Adults without HIV reported feeling younger than their chronologic age, whereas PLWH felt significantly closer to their chronologic age. SADS were negatively associated with only subjective NCF, among only PLWH. This suggests perceived cognitive functioning has a greater impact on psychological well-being among this group. Future research is warranted to delineate the relationship between HIV, subjective neurocognition, and psychosocial factors related to daily functioning to improve successful aging outcomes among this vulnerable population.
Collapse
|
36
|
Kasimanickam R, Kasimanickam V, Gold J, Moore D, Kastelic JP, Pyrdek D, Ratzburg K. Injectable or transdermal flunixin meglumine improves pregnancy rates in embryo transfer recipient beef cows without altering returns to estrus. Theriogenology 2019; 140:8-17. [PMID: 31421533 DOI: 10.1016/j.theriogenology.2019.08.011] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2019] [Revised: 07/10/2019] [Accepted: 08/07/2019] [Indexed: 12/31/2022]
Abstract
OBJECTIVES were to determine effects of 1) injectable or transdermal flunixin meglumine (FM) at embryo transfer (ET) compared to an untreated control group on pregnancy per ET (P/ET; ∼35 d after ET); 2) embryo and recipient factors on P/ET; 3) FM on hormone concentrations; and 4) FM on returns to estrus. Angus-cross beef cows (n = 1145) at five locations were scored for body condition (BCS; 1-9) and temperament (0 or 1) and given Select-Synch + CIDR. Recipient cows with a corpus luteum (CL) ≥1.5 cm received a frozen-thawed embryo 7 d after estrus and were concurrently given 1.1 mg/kg injectable FM im (INJFM; n = 384), 3.3 mg/kg transdermal FM pour on (TDFM; n = 388), or nothing (CON group; n = 373). Blood samples were collected at ET and 7 d later (60 cows). Accounting for temperament (P < 0.05), ET difficulty score (1-3, easy to difficult; P < 0.01), treatment by temperament (P < 0.001) and treatment by embryo quality (P < 0.05), FM treatments affected P/ET (P < 0.05). The P/ET for cows given INJFM [62.8% (241/384)] or TDFM [58.7% (228/388)] were not different (P = 0.26), but they were greater (P = 0.01 and P = 0.04, respectively) than P/ET for controls [51.2% (191/373)]. The P/ET was greater for calm versus excitable cows, 60.2 (463/769) and 52.4% (197/376), respectively (P < 0.01) and was lower for difficulty score 3 [49.2% (156/317)] compared to score 1 [62.7% (254/405; P < 0.001) or score 2 [59.1% (250/423; P < 0.01)]. There was no effect (P > 0.1) of cow age, BCS, or stage of embryo development on P/ET. Pregnancy rates for embryo quality grade 1 (excellent/good) and grade 2 (fair) were 60.4% (314/520) and 55.4% (346/625), respectively (P > 0.05). Percentages of non-pregnant recipient cows in estrus from Days 18-26 did not differ among treatment groups (P > 0.1). Control cows had lower progesterone concentrations and greater substance-P, PGFM and 8-isoprostane PGF2α concentrations at 7 d after ET compared to FM-treated cows (P < 0.05). In conclusion, injectable or transdermal FM improved pregnancy rates in ET recipients, without affecting nonpregnant cows return to estrus.
Collapse
Affiliation(s)
- R Kasimanickam
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA.
| | - V Kasimanickam
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA
| | - J Gold
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA
| | - D Moore
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA
| | - J P Kastelic
- Department of Production Animal Health, University of Calgary, Faculty of Veterinary Medicine, Calgary, AB, Canada
| | - D Pyrdek
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA
| | - K Ratzburg
- Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA, USA
| |
Collapse
|
37
|
Ggita JM, Ojok C, Meyer AJ, Farr K, Shete PB, Ochom E, Turimumahoro P, Babirye D, Mark D, Dowdy D, Ackerman S, Armstrong-Hough M, Nalugwa T, Ayakaka I, Moore D, Haberer JE, Cattamanchi A, Katamba A, Davis JL. Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda. Int J Tuberc Lung Dis 2019; 22:530-536. [PMID: 29663958 DOI: 10.5588/ijtld.17.0521] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Little information exists about mobile phone usage or preferences for tuberculosis (TB) related health communications in Uganda. METHODS We surveyed household contacts of TB patients in urban Kampala, Uganda, and clinic patients in rural central Uganda. Questions addressed mobile phone access, usage, and preferences for TB-related communications. We collected qualitative data about messaging preferences. RESULTS We enrolled 145 contacts and 203 clinic attendees. Most contacts (58%) and clinic attendees (75%) owned a mobile phone, while 42% of contacts and 10% of clinic attendees shared one; 94% of contacts and clinic attendees knew how to receive a short messaging service (SMS) message, but only 59% of contacts aged 45 years (vs. 96% of contacts aged <45 years, P = 0.0001) did so. All contacts and 99% of clinic attendees were willing and capable of receiving personal-health communications by SMS. Among contacts, 55% preferred detailed messages disclosing test results, while 45% preferred simple messages requesting a clinic visit to disclose results. CONCLUSIONS Most urban household TB contacts and rural clinic attendees reported having access to a mobile phone and willingness to receive TB-related personal-health communications by voice call or SMS. However, frequent phone sharing and variable messaging abilities and preferences suggest a need to tailor the design and monitoring of mHealth interventions to target recipients.
Collapse
Affiliation(s)
- J M Ggita
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - C Ojok
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - A J Meyer
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
| | - K Farr
- Division of Pulmonary and Critical Care Medicine, University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, California, USA; Curry International Tuberculosis Center, University of California San Francisco, San Francisco, California, USA
| | - P B Shete
- Division of Pulmonary and Critical Care Medicine, University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, California, USA; Curry International Tuberculosis Center, University of California San Francisco, San Francisco, California, USA
| | - E Ochom
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - P Turimumahoro
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - D Babirye
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - D Mark
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - D Dowdy
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
| | - S Ackerman
- Department of Social & Behavioral Sciences, University of California, San Francisco, San Francisco, California, USA
| | - M Armstrong-Hough
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA
| | - T Nalugwa
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - I Ayakaka
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda
| | - D Moore
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; London School of Hygiene & Tropical Medicine, London, England, UK
| | - J E Haberer
- Massachusetts General Hospital Global Health, Boston, Massachusetts, USA, Harvard Medical School, Boston, Massachusetts, USA
| | - A Cattamanchi
- Division of Pulmonary and Critical Care Medicine, University of California San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, California, USA; Curry International Tuberculosis Center, University of California San Francisco, San Francisco, California, USA
| | - A Katamba
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Clinical Epidemiology Unit, Department of Medicine, Makerere University, Kampala, Uganda
| | - J L Davis
- Uganda Tuberculosis Implementation Research Consortium, Makerere University, Kampala, Uganda; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA; Pulmonary, Critical Care, and Sleep Medicine Section, Yale School of Medicine, New Haven, Connecticut, USA
| |
Collapse
|
38
|
Meehan C, Greco B, Lynn B, Morfeld K, Vicino G, Orban D, Gorsuch C, Quick M, Ripple L, Fournier K, Moore D. The Elephant Welfare Initiative: a model for advancing evidence‐based zoo animal welfare monitoring, assessment and enhancement. ACTA ACUST UNITED AC 2019. [DOI: 10.1111/izy.12222] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C. Meehan
- AWARE Institute 3212 NW Wilson Street Portland Oregon97210‐1249USA
- School of Veterinary Medicine University of California, Davis Davis California95616USA
| | - B. Greco
- AWARE Institute 3212 NW Wilson Street Portland Oregon97210‐1249USA
- University of Wisconsin Department of Animal Science River Falls Wisconsin 54022USA
| | - B. Lynn
- AWARE Institute 3212 NW Wilson Street Portland Oregon97210‐1249USA
| | - K. Morfeld
- Kansas City Zoo Kansas City Missouri64132USA
| | - G. Vicino
- San Diego Zoo Global San Diego California92101USA
| | - D. Orban
- Cincinnati Zoo & Botanical Garden Cincinnati Ohio45220USA
| | - C. Gorsuch
- Cincinnati Zoo & Botanical Garden Cincinnati Ohio45220USA
| | - M. Quick
- Sedgwick County Zoo Wichita Kansas67212USA
| | - L. Ripple
- Sedgwick County Zoo Wichita Kansas67212USA
| | | | - D. Moore
- Oregon Zoo Portland Oregon97221USA
| |
Collapse
|
39
|
Moore D, Chong MS, Shetty A, Zakrzewska JM. A systematic review of rescue analgesic strategies in acute exacerbations of primary trigeminal neuralgia. Br J Anaesth 2019; 123:e385-e396. [PMID: 31208761 DOI: 10.1016/j.bja.2019.05.026] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 04/05/2019] [Accepted: 05/03/2019] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Trigeminal neuralgia (TN) can have a significant impact on wellbeing and quality of life. Limited data exist for treatments that improve TN pain acutely, within 24 h of administration. This systematic review aims to identify effective treatments that acutely relieve TN exacerbations. METHODS We searched Medline and Cochrane Central Register of Controlled Trials (CENTRAL) for relevant English language publications. The reference list for all articles was searched for other relevant publications. All studies that satisfied the following PICO criteria were included: (i) Population-adults with acute exacerbation of primary TN symptoms; (ii) Intervention-any medication or intervention with the primary goal of pain relief within 24 h; (iii) Comparator-usual medical care, placebo, sham or active treatment; (iv) Outcome-more than 50% reduction in pain intensity within 24 h of administration. RESULTS Of 431 studies, 17 studies were identified that reported immediate results of acute treatment in TN. The evidence suggests that the following interventions may be beneficial: local anaesthetic, mainly lidocaine (ophthalmic, nasal or oral mucosa, trigger point injection, i.v. infusion, nerve block); anticonvulsant, phenytoin or fosphenytoin (i.v. infusion); serotonin agonist, sumatriptan (s.c. injection, nasal). Other referenced interventions with very limited evidence include N-methyl-d-aspartate receptor antagonist (magnesium sulphate infusion) and botulinum toxin (trigger point injection). CONCLUSIONS Several treatment options exist that may provide fast and safe relief of TN. Future studies should report on outcomes within 24 h to improve knowledge of the acute analgesic TN treatments.
Collapse
Affiliation(s)
- D Moore
- Department of Anaesthesia, Beaumont Hospital, Dublin, Ireland
| | - M S Chong
- University College London Hospital, London, UK
| | - A Shetty
- University College London Hospital, London, UK
| | | |
Collapse
|
40
|
Nisbet S, Mahalingam H, Gfeller CF, Biggs E, Lucas S, Thompson M, Cargill MR, Moore D, Bielfeldt S. Cosmetic benefit of a biomimetic lamellar cream formulation on barrier function or the appearance of fine lines and wrinkles in randomized proof-of-concept clinical studies. Int J Cosmet Sci 2019; 41:1-11. [PMID: 30414275 PMCID: PMC6849859 DOI: 10.1111/ics.12499] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2018] [Accepted: 11/05/2018] [Indexed: 12/21/2022]
Abstract
Objective Two studies were designed to evaluate the potential cosmetic benefit of a biomimetic, niacinamide‐containing moisturizing cream for the first time in humans. Methods In both studies, healthy women were randomized to use two treatments, one for the left side of the body and one for the right, from three options: the test cream, a positive control or no treatment (use of standard cleanser only). Treatments were applied twice daily for 4 weeks to the face and forearms (Study 1) or the face only (Study 2). Instrumental and clinical skin assessments were performed by trained technicians. Study 1 involved tape stripping and a 5‐day no‐treatment (‘regression’) period at the end of the 4 weeks. Independent lay graders were asked to grade the skin texture of subjects in Study 2 from high‐resolution photographs. Results In Study 1 (n = 66), the test cream significantly decreased the transepidermal water loss (TEWL) values on the forearm, and in the cheek area of the face, relative to baseline and compared to no treatment, and increased skin Corneometer values. The improvements were partially retained during a subsequent 5‐day period of no treatment. Increases in TEWL values on skin subjected to tape stripping were significantly lower after 4 weeks of using the test cream compared to no treatment. In Study 2 (n = 72 subjects with visible signs of ageing), there was a favourable trend in the change from baseline of a skin roughness parameter, Ra, for the test cream compared to no treatment. There were statistically significant improvements in the Fitzpatrick wrinkle score compared to no treatment, decreases in TEWL and increased Corneometer values and Cutometer values (R5 elasticity parameter). Grading of high‐resolution images failed to detect the improvements in skin texture (defined as pores, smoothness and unevenness) for the test cream vs. no treatment. No treatment‐related serious or severe adverse events were reported. Conclusion Twice daily application of the test cream over 4 weeks had beneficial effects on skin barrier function, moisturization, wrinkle dimensions and elasticity compared to no treatment. These studies provide proof‐of‐concept evidence and highlight the cosmetic benefit of the biomimetic lamellar cream formulation. Study registration: NCT03216265, NCT03180645.
Collapse
Affiliation(s)
- S Nisbet
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - H Mahalingam
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, 184 Liberty Corner Road, Warren, NJ 07059, U.S.A
| | - C F Gfeller
- GlaxoSmithKline Consumer Healthcare, Medical Affairs - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - E Biggs
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - S Lucas
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - M Thompson
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - M R Cargill
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - D Moore
- GlaxoSmithKline Consumer Healthcare, Research and Development - Skin Health, St George's Avenue, Weybridge, KT13 0DE, U.K
| | - S Bielfeldt
- proDERM Institute for Applied Dermatological Research, Kiebitzweg 2, Schenefeld/Hamburg, 22869, Germany
| |
Collapse
|
41
|
Na B, Yu X, Wither T, Gilleran J, Yao M, Foo TK, Chen C, Moore D, Xia B, Lin Y, Kimball D, Ganesan S, Carpizo D. Abstract P6-20-05: Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p6-20-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Triple negative breast cancer (TNBC) is an aggressive subset for which novel therapeutic approaches are needed. A significant proportion of TNBC patients harbor either germline or somatic mutations in BRCA1, or epigenetic silencing of BRCA1, which renders them deficient in DNA repair. Virtually all BRCA1 deficient breast cancers harbor mutations in TP53 suggesting that inactivation of p53 is a requirement for tumor progression in the setting of BRCA1 deficiency. Due to this dependency, we hypothesized that restoring wild type p53 function in BRCA1 deficient breast cancer would be therapeutic. The majority of TP53 mutations are missense, which generate a defective protein that potentially can be targeted with small molecules. Zinc Metallochaperones (ZMCs) are a new class of anti-cancer drugs that reactivate a class of zinc deficient mutant TP53 alleles by restoring zinc binding. Using ZMC1 in human breast cancer cell lines expressing the zinc deficient p53R175H, we demonstrate that loss of BRCA1 sensitizes cells to mutant p53 reactivation. Using genetically engineered murine mammary tumor models with Brca1 deficiency, we demonstrate that ZMC1 significantly improves survival in mice bearing tumors harboring the zinc deficient Trp53R172H allele but not the Trp53 null allele. We synthesized a novel formulation of ZMC1 (Zn-1), in which the drug is made in complex with zinc to improve zinc delivery, and demonstrate that Zn-1 has increased efficacy over ZMC1. Furthermore, we show that ZMC1 plus olaparib is a highly effective combination for tumors expressing the p53R172H mutant. In conclusion, we have validated preclinically a novel therapeutic approach for BRCA1 deficient breast cancer through reactivation of mutant p53.
Citation Format: Na B, Yu X, Wither T, Gilleran J, Yao M, Foo TK, Chen C, Moore D, Xia B, Lin Y, Kimball D, Ganesan S, Carpizo D. Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P6-20-05.
Collapse
Affiliation(s)
- B Na
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - X Yu
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - T Wither
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - J Gilleran
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - M Yao
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - TK Foo
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - C Chen
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - D Moore
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - B Xia
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - Y Lin
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - D Kimball
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - S Ganesan
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| | - D Carpizo
- Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Rutgers University, Piscataway, NJ
| |
Collapse
|
42
|
Mc Auliffe C, Morrissey E, Vaughan M, Moore D, Collins R. The Role of the Pharmacist in a Multi-Disciplinary Atrial Fibrillation Clinic. Ir Med J 2019; 112:850. [PMID: 30718225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Affiliation(s)
- C Mc Auliffe
- Pharmacy Department, Tallaght University Hospital, Dublin
| | - E Morrissey
- Pharmacy Department, Tallaght University Hospital, Dublin
| | - M Vaughan
- Pharmacy Department, Tallaght University Hospital, Dublin
| | - D Moore
- Cardiology Department, Tallaght University Hospital, Dublin
| | - R Collins
- Department of Age-Related Health Care/Stroke Service, Tallaght University Hospital, Dublin
| |
Collapse
|
43
|
Moore D, Maddox A, Gillibrand R, Medeiros F. Is the current strategy for stratifying patients for targeted therapy use in NSCLC really logical and sustainable? Results from a retrospective study suggest otherwise. Lung Cancer 2019. [DOI: 10.1016/s0169-5002(19)30098-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
44
|
Wishner KF, Seibel BA, Roman C, Deutsch C, Outram D, Shaw CT, Birk MA, Mislan KAS, Adams TJ, Moore D, Riley S. Ocean deoxygenation and zooplankton: Very small oxygen differences matter. Sci Adv 2018; 4:eaau5180. [PMID: 30585291 PMCID: PMC6300398 DOI: 10.1126/sciadv.aau5180] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/18/2018] [Accepted: 11/21/2018] [Indexed: 06/09/2023]
Abstract
Oxygen minimum zones (OMZs), large midwater regions of very low oxygen, are expected to expand as a result of climate change. While oxygen is known to be important in structuring midwater ecosystems, a precise and mechanistic understanding of the effects of oxygen on zooplankton is lacking. Zooplankton are important components of midwater food webs and biogeochemical cycles. Here, we show that, in the eastern tropical North Pacific OMZ, previously undescribed submesoscale oxygen variability has a direct effect on the distribution of many major zooplankton groups. Despite extraordinary hypoxia tolerance, many zooplankton live near their physiological limits and respond to slight (≤1%) changes in oxygen. Ocean oxygen loss (deoxygenation) may, thus, elicit major unanticipated changes to midwater ecosystem structure and function.
Collapse
Affiliation(s)
- K. F. Wishner
- Graduate School of Oceanography, University of Rhode Island, Narragansett, RI 02882, USA
| | - B. A. Seibel
- College of Marine Science, University of South Florida, St. Petersburg, FL 33701, USA
| | - C. Roman
- Graduate School of Oceanography, University of Rhode Island, Narragansett, RI 02882, USA
| | - C. Deutsch
- School of Oceanography, University of Washington, Seattle, WA 98195, USA
- Department of Biology, University of Washington, Seattle, WA 98195, USA
| | - D. Outram
- Graduate School of Oceanography, University of Rhode Island, Narragansett, RI 02882, USA
| | - C. T. Shaw
- College of Marine Science, University of South Florida, St. Petersburg, FL 33701, USA
| | - M. A. Birk
- College of Marine Science, University of South Florida, St. Petersburg, FL 33701, USA
| | - K. A. S. Mislan
- School of Oceanography, University of Washington, Seattle, WA 98195, USA
- eScience Institute, University of Washington, Seattle, WA 98195, USA
| | - T. J. Adams
- Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA
| | - D. Moore
- Graduate School of Oceanography, University of Rhode Island, Narragansett, RI 02882, USA
| | - S. Riley
- Graduate School of Oceanography, University of Rhode Island, Narragansett, RI 02882, USA
- Oregon State University, Corvallis, OR 97331, USA
| |
Collapse
|
45
|
Paolillo E, Saloner R, Montoya J, Campbell L, Pasipanodya E, Iudicello J, Moore R, Moore D. C - 26Combined Effects of HIV and Past Methamphetamine Use Disorder on Frailty, Neurocognition, and Everyday Functioning. Arch Clin Neuropsychol 2018. [DOI: 10.1093/arclin/acy061.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
46
|
Kushnir M, Winter H, Murias C, Bains P, Abbosh C, Papadatos-Pastos D, Newsome-Davis T, Ahmed T, Swanton C, Forster M, Moore D, Bennett P, Faull I, Lanman R, Arkenau HT. Cell-free circulating tumour DNA (ctDNA) in the management of patients with non-biopsiable advanced non-small cell lung cancer (NSCLC). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
47
|
Kress K, Amos A, Flieg L, Louwagie M, Moore D. Teaching Management and Research Competencies in Graduate Education through Student Participation in Hospital Quality Assurance reporting for Malnutrition Prevalence and Reimbursement. J Acad Nutr Diet 2018. [DOI: 10.1016/j.jand.2018.08.075] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
48
|
Winter H, Faull I, Bains P, Murias C, Kushnir M, Forster M, Kulkarni A, Moore D, Swanton C, Shiu K, Arkenau HT. Circulating tumour DNA experience in patients with cancer of unknown primary. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy269.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
49
|
Abstract
Research on pain in autism spectrum disorder (ASD) is in its infancy, with almost nothing known about how individual differences may predicting pain response in ASD. In the present study, 45 adults (28 male, age 22-48 years) with diagnoses of autism and intellectual delay were observed during vaccination or dental cleaning and their pain behaviours coded and measures of autism symptom severity, anxiety, depression and obsessivity taken. Our findings showed that greater autism severity predicted greater pain response which was partially mediated by anxiety and depression. These data suggest that mental health symptoms are important when considering pain response in autism. Mood must therefore be considered in future research on pain in ASD as well as clinical pain management.
Collapse
Affiliation(s)
- D Garcia-Villamisar
- Unit of Psychopathology, Department of Personality and Clinical Psychology, Complutense University of Madrid, Madrid, Spain.
- Asociación Nuevo Horizonte, 28231, Las Rozas, Madrid, Spain.
| | - D Moore
- Psychology Department, School of Natural Science and Psychology, Liverpool John Moores University, Liverpool, L3 3AF, UK
- Research Centre for Brain and Behaviour, Liverpool John Moores University, Liverpool, UK
| | - M Garcia-Martínez
- Unit of Psychopathology, Department of Personality and Clinical Psychology, Complutense University of Madrid, Madrid, Spain
| |
Collapse
|
50
|
Wang J, Moore D, Subramanian A, Cheng KK, Toulis KA, Qiu X, Saravanan P, Price MJ, Nirantharakumar K. Gestational dyslipidaemia and adverse birthweight outcomes: a systematic review and meta-analysis. Obes Rev 2018; 19:1256-1268. [PMID: 29786159 DOI: 10.1111/obr.12693] [Citation(s) in RCA: 57] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/30/2017] [Revised: 01/30/2018] [Accepted: 02/26/2018] [Indexed: 12/15/2022]
Abstract
BACKGROUND Low and high birthweight is known to increase the risk of acute and longer-term adverse outcomes, such as stillbirth, infant mortality, obesity, type 2 diabetes and cardiovascular diseases. Gestational dyslipidaemia is associated with a numbers of adverse birth outcomes, but evidence regarding birthweight is still inconsistent to reliably inform clinical practice and treatment recommendations. OBJECTIVE The aim of this study was to explore the relationship between maternal gestational dyslipidaemia and neonatal health outcomes, namely, birthweight, metabolic factors and inflammatory parameters. METHODS We searched systematically Embase, MEDLINE, PubMed, CINAHL Plus and Cochrane Library up to 1 August 2016 (with an updated search in MEDLINE at the end of July 2017) for longitudinal studies that assessed the association of maternal lipid levels during pregnancy with neonatal birthweight, or metabolic and inflammatory parameters up to 3 years old. RESULTS Data from 46 publications including 31,402 pregnancies suggest that maternal high triglycerides and low high-density-lipoprotein cholesterol levels throughout pregnancy are associated with increased birthweight, higher risk of large for gestational age and macrosomia and lower risk of small-for-gestational age. The findings were consistent across the studied populations, but stronger associations were observed in women who were overweight or obese prior to pregnancy. CONCLUSIONS This meta-analysis suggested that the potential under-recognized adverse effects of intrauterine exposure to maternal dyslipidaemia may warrant further investigation into the relationship between maternal dyslipidaemia and birthweight in large prospective cohorts or in randomized trials.
Collapse
Affiliation(s)
- J Wang
- Division of Birth Cohort Study, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, China.,Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - D Moore
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - A Subramanian
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - K K Cheng
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - K A Toulis
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - X Qiu
- Division of Birth Cohort Study, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, China
| | - P Saravanan
- Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK
| | - M J Price
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| | - K Nirantharakumar
- Institute of Applied Health Research, University of Birmingham, Birmingham, UK
| |
Collapse
|